Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

UTMD stock hub

Utah Medical Products, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

UTMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

208.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

UTMD

In the news

Latest news · UTMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E19.3

P25 14.9P50 23.2P75 38.5

ROE9.1

P25 -105.6P50 -46.5P75 -3.1

ROIC29.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All UTMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000706698
Company name	Utah Medical Products, Inc.
Country	United States
Country code	US
Cusip	917488108
Employees	152
Employees Change	-15%
Employees Change Percent	-8.98
Enterprise value	$120.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Isin	US9174881089
Last refreshed	2026-05-10
Market cap	$208.1M
Market cap category	Micro-Cap
Price	$65.35
Price currency	USD
Rev Per Employee	246,921.05x
Sector	Healthcare
Sic	3841
Symbol	UTMD
Website	https://www.utahmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.21%
EV Earnings	11.14x
EV/EBIT	9.93x
EV/EBITDA	7.98x
EV/Sales	3.22x
P/B ratio	1.73x
P/E ratio	19.33x
P/S ratio	5.54x
PE Ratio10 Y	22.01x
PE Ratio3 Y	16.48x
PE Ratio5 Y	18.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.42%
EBITDA Margin	40.36%
Gross margin	57.94%
Gross Profit	$21.7M
Gross Profit Growth	-5.11%
Gross Profit Growth Q	-4.62%
Gross Profit Growth3 Y	-12.54%
Gross Profit Growth5 Y	-3.26%
Net Income	$10.8M
Net Income Growth	-16.28%
Net Income Growth Q	-14.37%
Net Income Growth Years	0%
Net Income Growth3 Y	-14.16%
Net Income Growth5 Y	0.31%
Pretax Margin	35.79%
Profit Margin	28.91%
Profit Per Employee	$71,375
Profitable Years	32
ROA	6.16
Roa5y	8.58
ROCE	10.07
ROE	9.14
Roe5y	12.7
ROIC	29.35
Roic5y	34.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.64%
Cagr15y	7.82%
Cagr1y	23.73%
Cagr20y	6.24%
Cagr3y	-9.69%
Cagr5y	-4.24%
Div CAGR10	1.78%
Div CAGR3	1.67%
Div CAGR5	1.7%
EPS Growth	-10.62
EPS Growth Q	-11.01
EPS Growth Years	0
EPS Growth3 Y	-10.54
EPS Growth5 Y	2.95
Revenue Growth	-4.43x
Revenue Growth Q	-10.18x
Revenue Growth Years	0x
Revenue Growth3 Y	-10.57x
Revenue Growth5 Y	-2.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.3
Assets	$124.4M
Cash	$87.4M
Current Assets	$100.4M
Current Liabilities	$3.5M
Debt	$210,000
Debt EBITDA	$0.01
Debt Equity	$0
Equity	$120.4M
Liabilities	$4M
Long Term Assets	$24M
Long Term Liabilities	$504,000
Net Cash	$87.2M
Net Cash By Market Cap	$41.91
Net Cash Growth	4.98%
Net Debt EBITDA	$-5.76
Net Debt Equity	$-0.72
Tangible Book Value	$106.1M
Tangible Book Value Per Share	$33.32
WACC	6.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	28.64
Inventory Turnover	1.82
Net Working Capital	$9.5M
Quick ratio	25.97
Working Capital	$96.9M
Working Capital Turnover	$0.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.35%
Dividend Growth	1.65%
Dividend Growth Years	3%
Dividend per share	$1.24
Dividend Years	23
Dividend Yield	1.9%
Ex Div Date	2026-06-17
Last Dividend	$0.31
Payout Frequency	Quarterly
Payout Ratio	36.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	17.67%
1Y total return	23.71%
200-day SMA	61.1
3Y total return	-26.36%
50-day SMA	65.39
50-day SMA vs 200-day SMA	50over200
5Y total return	-19.47%
All Time High	133.9
All Time High Change	-51.18%
All Time High Date	2021-11-22
All Time Low	1.96
All Time Low Change	3,237.59%
All Time Low Date	1989-03-21
ATR	1.7
Beta	0.37
Beta1y	0.97
Beta2y	0.61
Ch YTD	16.78
High	65.98
High52	71.81
High52 Date	2026-04-17
High52ch	-8.99%
Low	64.71
Low52	52
Low52 Date	2025-06-20
Low52ch	25.67%
Ma50ch	-0.06%
Price vs 200-day SMA	6.96%
RSI	47.03
RSI Monthly	50.4
RSI Weekly	54.79
Sharpe ratio	0.85x
Sortino ratio	1.58
Total Return	8.24%
Tr YTD	17.35
Tr15y	209.57%
Tr1m	2.96%
Tr1w	-0.64%
Tr3m	6.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$12.2M
Operating Income Growth	-16.46
Operating Income Growth Q	-26.02
Operating Income Growth3 Y	-16.26
Operating Income Growth5 Y	-2.39
Operating margin	32.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,761,795%
Float Percent	86.74%
Shares Insiders	7.18%
Shares Institutions	61.7%
Shares Out	3,184,025
Shares Qo Q	-0.39%
Shares Yo Y	-6.35%
Short Float	4.96%
Short Ratio	9.43
Short Shares	4.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,647.15x
Bv Per Share	37.81
Ch10y	0.08
Ch15y	134.1
Ch1m	2.96
Ch1w	-0.64
Ch1y	21.18
Ch20y	110.8
Ch3m	6.02
Ch3y	-30.24
Ch5y	-26.8
Ch6m	13.85
Change	-0.08%
Change From Open	-0.61
Close	65.4
Days Gap	0.54
Depreciation Amortization	2,981,000
Dollar Volume	592,049.8
Earnings Date	2026-04-23
Earnings Time	bmo
EBIT	$12.2M
EBITDA	$15.1M
EPS	$3.38
F Score	4
Fiscal Year End	December
Founded	1,978
Graham Number	53.62677
Graham Upside	-17.94
Income Tax	$2.6M
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	1993-03-22
Last Split Type	Forward
Last10k Filing Date	2026-03-27
Lynch Fair Value	$16.9
Lynch Upside	-74.13
Ma150	61.44
Ma150ch	6.37%
Ma20	67.15
Ma20ch	-2.67%
Next Earnings Date	2026-07-23
Open	65.75
Optionable	No
Payment Date	2026-07-03
Position In Range	50.39
Post Close	65.35
Postmarket Change Percent	-0.5
Postmarket Price	$65.02
Ppne	9,721,000
Price Date	2026-05-08
Price EBITDA	$13.74
Ptbv Ratio	1.96
Relative Volume	0.78x
Revenue	37,532,000x
Tax By Revenue	6.88x
Tax Rate	19.24%
Tr20y	235.29%
Tr6m	15.03%
Us State	Utah
Volume	9,059.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

UTMD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$1.24 annual per share

Payout ratio

+36.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.7%

3 consecutive years of growth

Total shareholder yield

+8.2%

Next ex-dividend date: 2026-06-17

Performance

UTMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns UTMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+61.7%

Float: +86.7% of shares outstanding

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

UTMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.0

Neutral momentum band

Price vs 200-day MA

+7.0%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About UTMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current UTMD stock rating?

Utah Medical Products, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full UTMD analysis?

The full report lives at /stocks/UTMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for UTMD?

The latest report frames UTMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the UTMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.